Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directoryClinical-trial AI company using disease-specific machine learning models to generate participant-level digital twins for trial analysis.
Sponsors exploring smaller or more informative control arms, single-arm study context, interim looks, or trial power improvements with statistical review.
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Unlearn as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as clinical trial methodology and evidence-generation infrastructure that needs protocol, SAP, ethics, sponsor, and regulator review before affecting enrollment or analysis. |
|---|---|
| Privacy | Review trial-participant data flows, baseline-variable scope, consent, de-identification, retention, transfers, automated-decision disclosures, and sponsor agreements. |
| Evidence | Inspect disease-model validation, calibration, external generalizability, uncertainty intervals, bias testing, and whether assumptions match the endpoint and population. |
| Workflow | Best used with biostatistical governance where digital-twin outputs are versioned, auditable, and reconciled with trial operations and regulatory commitments. |
Unlearn describes digital twins as AI-generated forecasts of individual trial participants' control outcomes using baseline data and historical clinical data; its privacy notice says AI is used to support clinical trial design and analysis rather than automated decisions about website visitors or customers.
Not for: Replacing randomized evidence, patient-level treatment decisions, or regulatory strategy without protocol-specific statistical, clinical, ethics, and agency review.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.